Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Nomogram incorporating Epstein-Barr virus DNA and a novel immune-nutritional marker for survival prediction in nasopharyngeal carcinoma

Fig. 3

Kaplan–Meier survival curves of PFS and OS based on different groups between LA combined with EBV DNA in the training and validation cohorts. a Survival curves for PFS in the training cohort; b Survival curves for PFS in the validation cohort; c Survival curves for OS in the training cohort; d Survival curves for OS in the validation cohort. Worse prognosis was observed in patients with Group 4 (patients with low LA and positive EBV DNA)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us